Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.

Reza MobiniValentina TremaroliMarcus StåhlmanFredrik KarlssonMax LevinMaria LjungbergMaja SohlinHeléne Bertéus ForslundRosie PerkinsFredrik BäckhedPer-Anders Jansson

Published in: Diabetes, obesity & metabolism (2017)

Intake of L. reuteri DSM 17938 for 12 weeks did not affect HbA1c in people with type 2 diabetes on insulin therapy; however, L. reuteri improved insulin sensitivity in a subset of participants and we propose that high diversity of the gut microbiota at baseline may be important.

Keyphrases

type diabetes
glycemic control
stem cells
weight gain
body mass index
smoking cessation
lactic acid